Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Racecadotril - Bioproject

Drug Profile

Racecadotril - Bioproject

Alternative Names: Acetorphan; Hidrasec; Racemic acetorphan; Tiorfan; Tiorfast; Tiorfix

Latest Information Update: 10 Oct 2018

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bioprojet
  • Developer Abbott Laboratories; Bago; Bioprojet; Ferrer; GlaxoSmithKline; Leti; Nordic Drugs; Takeda
  • Class Antidiarrhoeals; Antisecretories; Benzyl compounds; Esters; Small molecules; Sulfhydryl compounds; Sulfur amino acids
  • Mechanism of Action Neprilysin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Diarrhoea

Most Recent Events

  • 10 Sep 2018 Abbott completes a phase III trial for Diarrhoea (In infants, In children, In adolescents) in Russia (PO) (NCT03463512)
  • 25 Aug 2018 Phase-III clinical trials in Diarrhoea (In infants, In children) in Taiwan (PO) (NCT03473561)
  • 29 Mar 2018 Phase-III clinical trials in Diarrhoea (In adolescents, In children, In infants) in Russia (PO) (NCT03463512)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top